JPMorgan Chase & Co’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
|
|||||
|
2025
Q1 | $2.01M | Sell |
|
|||||
|
2024
Q4 | $3.32M | Sell |
|
|||||
|
2024
Q3 | $4.23M | Buy |
|
|||||
|
2024
Q2 | $1.16M | Buy |
|
|||||
|
2024
Q1 | $781K | Buy |
|
|||||
|
2023
Q4 | $438K | Sell |
|
|||||
|
2023
Q3 | $232K | Buy |
|
|||||
|
2023
Q2 | $276K | Buy |
|
|||||
|
2023
Q1 | $210K | Buy |
|
|||||
|
2022
Q4 | $217K | Buy |
|
|||||
|
2022
Q3 | $195K | Sell |
|
|||||
|
2022
Q2 | $168K | Sell |
|
|||||
|
2022
Q1 | $263K | Buy |
|
|||||
|
2021
Q4 | $337K | Buy |
|
|||||
|
2021
Q3 | $124K | Sell |
|
|||||
|
2021
Q2 | $216K | Buy |
|